Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation

被引:101
作者
Meinel, Thomas R. [1 ,2 ]
Branca, Mattia [3 ]
De Marchis, Gian Marco [4 ,5 ,6 ]
Nedeltchev, Krassen [7 ]
Kahles, Timo [7 ]
Bonati, Leo [4 ,5 ,6 ]
Arnold, Marcel [1 ,2 ]
Heldner, Mirjam R. [1 ,2 ]
Jung, Simon [1 ,2 ]
Carrera, Emmanuel [8 ]
Dirren, Elisabeth [8 ]
Michel, Patrik [9 ]
Strambo, Davide [9 ]
Cereda, Carlo W. [10 ]
Bianco, Giovanni [10 ]
Kagi, Georg [11 ]
Vehoff, Jochen [11 ]
Katan, Mira [12 ]
Bolognese, Manuel [13 ]
Backhaus, Roland [14 ]
Salmen, Stephan [15 ]
Albert, Sylvan [16 ]
Medlin, Friedrich [17 ]
Berger, Christian [18 ]
Schelosky, Ludwig [19 ]
Renaud, Susanne [20 ]
Niederhauser, Julien [21 ]
Bonvin, Christophe [22 ]
Schaerer, Michael [23 ]
Mono, Marie-Luise [24 ]
Rodic, Biljana [25 ]
Tarnutzer, Alexander A. [26 ]
Mordasini, Pasquale [2 ,27 ]
Gralla, Jan [2 ,27 ]
Kaesmacher, Johannes [2 ,28 ]
Engelter, Stefan [4 ,5 ,6 ,29 ]
Fischer, Urs [1 ,2 ]
Seiffge, David J. [1 ,2 ]
机构
[1] Bern Univ Hosp, Inselspital, Dept Neurol, Bern, Switzerland
[2] Univ Bern, Bern, Switzerland
[3] Univ Bern, Clinicial Trials Unit Bern, Bern, Switzerland
[4] Univ Hosp Basel, Dept Neurol, Basel, Switzerland
[5] Univ Hosp Basel, Stroke Ctr, Basel, Switzerland
[6] Univ Basel, Basel, Switzerland
[7] Kantonsspital Aarau, Dept Neurol, Aarau, Switzerland
[8] Hop Univ Geneve, Dept Neurol, Geneva, Switzerland
[9] Lausanne Univ Hosp, Stroke Ctr, Neurol Serv, Lausanne, Switzerland
[10] Neuroctr Southern Switzerland, Stroke Ctr, Lugano, Switzerland
[11] Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland
[12] Univ Hosp Zurich, Dept Neurol, Basel, Switzerland
[13] Cantonal Hosp Lucerne, Neuroctr, Luzern, Switzerland
[14] Hirslanden Hosp Zurich, Glattpark, Switzerland
[15] Spitalzentrum Biel, Biel, Switzerland
[16] Cantonal Hosp Graubuenden, Chur, Switzerland
[17] Cantonal Hosp Fribourg, Stroke Unit, Fribourg, Switzerland
[18] Spital Sarganserland Grabs, Grabs, Switzerland
[19] Cantonal Hosp Munsterlingen, Neurol, Munsterlingen, Switzerland
[20] Cantonal Hosp Neuchatel, Neurol, Neuchatel, Switzerland
[21] Grp Hosp Ouest Leman, Stroke Unit, Nyon, Switzerland
[22] Hop Valais, Sion, Switzerland
[23] Burgerspital, Solothurn, Switzerland
[24] Stadtspital Waid & Triemli, Zurich, Switzerland
[25] Cantonal Hosp Winterthur, Winterthur, Switzerland
[26] Cantonal Hosp Baden, Baden, Switzerland
[27] Bern Univ Hosp, Inselspital, Inst Diagnost & Intervent Neuroradiol, Bern, Switzerland
[28] Bern Univ Hosp, Inselspital, Inst Diagnost & Intervent Neuroradiol, Inst Diagnost Intervent & Pediat Radiol,Dept Neur, Bern, Switzerland
[29] Univ Basel, Univ Dept Geriat Med Felix Platter, Neurol & Neurorehabil, Basel, Switzerland
关键词
PRECEDING ANTITHROMBOTIC TREATMENT; ANTAGONIST ORAL ANTICOAGULANTS; INTRAVENOUS THROMBOLYSIS; PLASMA-LEVELS; EMERGENCY MANAGEMENT; REPERFUSION THERAPY; DABIGATRAN; SEVERITY; SAFETY; COMPLICATIONS;
D O I
10.1002/ana.25917
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective The aim was to evaluate, in patients with atrial fibrillation (AF) and acute ischemic stroke, the association of prior anticoagulation with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) with stroke severity, utilization of intravenous thrombolysis (IVT), safety of IVT, and 3-month outcomes. Methods This was a cohort study of consecutive patients (2014-2019) on anticoagulation versus those without (controls) with regard to stroke severity, rates of IVT/mechanical thrombectomy, symptomatic intracranial hemorrhage (sICH), and favorable outcome (modified Rankin Scale score 0-2) at 3 months. Results Of 8,179 patients (mean [SD] age, 79.8 [9.6] years; 49% women), 1,486 (18%) were on VKA treatment, 1,634 (20%) on DOAC treatment at stroke onset, and 5,059 controls. Stroke severity was lower in patients on DOACs (median National Institutes of Health Stroke Scale 4, [interquartile range 2-11]) compared with VKA (6, [2-14]) and controls (7, [3-15],p < 0.001; quantile regression: beta -2.1, 95% confidence interval [CI] -2.6 to -1.7). The IVT rate in potentially eligible patients was significantly lower in patients on VKA (156 of 247 [63%]; adjusted odds ratio [aOR] 0.67; 95% CI 0.50-0.90) and particularly in patients on DOACs (69 of 464 [15%]; aOR 0.06; 95% CI 0.05-0.08) compared with controls (1,544 of 2,504 [74%]). sICH after IVT occurred in 3.6% (2.6-4.7%) of controls, 9 of 195 (4.6%; 1.9-9.2%; aOR 0.93; 95% CI 0.46-1.90) patients on VKA and 2 of 65 (3.1%; 0.4-10.8%, aOR 0.56; 95% CI 0.28-1.12) of those on DOACs. After adjustments for prognostic confounders, DOAC pretreatment was associated with a favorable 3-month outcome (aOR 1.24; 1.01-1.51). Interpretation Prior DOAC therapy in patients with AF was associated with decreased admission stroke severity at onset and a remarkably low rate of IVT. Overall, patients on DOAC might have better functional outcome at 3 months. Further research is needed to overcome potential restrictions for IVT in patients taking DOACs. ANN NEUROL 2020
引用
收藏
页码:42 / 53
页数:12
相关论文
共 39 条
[21]   Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants [J].
Purrucker, Jan C. ;
Wolf, Marcel ;
Haas, Kirsten ;
Rizos, Timolaos ;
Khan, Shujah ;
Dziewas, Rainer ;
Kleinschnitz, Christoph ;
Binder, Andreas ;
Groeschel, Klaus ;
Hennerici, Michael G. ;
Lobotesis, Kyriakos ;
Poli, Sven ;
Seidel, Guenter ;
Neumann-Haefelin, Tobias ;
Ringleb, Peter A. ;
Heuschmann, Peter U. ;
Veltkamp, Roland .
STROKE, 2016, 47 (04) :1127-1130
[22]   Oral Anticoagulants - A Frequent Challenge for the Emergency Management of Acute Ischemic Stroke [J].
Rizos, Timolaos ;
Horstmann, Solveig ;
Jenetzky, Ekkehart ;
Spindler, Marcia ;
Gumbinger, Christoph ;
Moehlenbruch, Markus ;
Ringleb, Peter ;
Hacke, Werner ;
Veltkamp, Roland .
CEREBROVASCULAR DISEASES, 2012, 34 (5-6) :411-418
[23]   Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials [J].
Ruff, Christian T. ;
Giugliano, Robert P. ;
Braunwald, Eugene ;
Hoffman, Elaine B. ;
Deenadayalu, Naveen ;
Ezekowitz, Michael D. ;
Camm, A. John ;
Weitz, Jeffrey I. ;
Lewis, Basil S. ;
Parkhomenko, Alexander ;
Yamashita, Takeshi ;
Antman, Elliott M. .
LANCET, 2014, 383 (9921) :955-962
[24]   Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation [J].
Salazar, Carlos A. ;
del Aguila, Daniel ;
Cordova, Erika G. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (03)
[25]   Management of patients with stroke treated with direct oral anticoagulants [J].
Seiffge, D. J. ;
Polymeris, A. A. ;
Fladt, J. ;
Lyrer, P. A. ;
Engelter, S. T. ;
De Marchis, Gian Marco .
JOURNAL OF NEUROLOGY, 2018, 265 (12) :3022-3033
[26]   Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage [J].
Seiffge, David J. ;
Kagi, Georg ;
Michel, Patrik ;
Fischer, Urs ;
Bejot, Yannick ;
Wegener, Susanne ;
Zedde, Marialuisa ;
Turc, Guillaume ;
Cordonnier, Charlotte ;
Sandor, Peter S. ;
Rodier, Gilles ;
Zini, Andrea ;
Cappellari, Manuel ;
Schadelin, Sabine ;
Polymeris, Alexandros A. ;
Werring, David ;
Thilemann, Sebastian ;
Maestrini, Ilaria ;
Berge, Eivind ;
Traenka, Christopher ;
Vehoff, Jochen ;
De Marchis, Gian Marco ;
Kapauer, Monika ;
Peters, Nils ;
Sirimarco, Gaia ;
Bonati, Leo H. ;
Arnold, Marcel ;
Lyrer, Philippe A. ;
De Maistre, Emmanuel ;
Luft, Andreas ;
Tsakiris, Dimtrios A. ;
Engelter, Stefan T. .
ANNALS OF NEUROLOGY, 2018, 83 (03) :451-459
[27]   Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice [J].
Seiffge, David J. ;
Traenka, Christopher ;
Polymeris, Alexandros A. ;
Thilemann, Sebastian ;
Wagner, Benjamin ;
Hert, Lisa ;
Mueller, Mandy D. ;
Gensicke, Henrik ;
Peters, Nils ;
Nickel, Christian H. ;
Stippich, Christoph ;
Sutter, Raoul ;
Marsch, Stephan ;
Fisch, Urs ;
Guzman, Raphael ;
De Marchis, Gian Marco ;
Lyrer, Philippe A. ;
Bonati, Leo H. ;
Tsakiris, Dimitrios A. ;
Engelter, Stefan T. .
JOURNAL OF STROKE, 2017, 19 (03) :347-+
[28]   Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke [J].
Seiffge, David J. ;
Traenka, Christopher ;
Polymeris, Alexandros ;
Hert, Lisa ;
Fisch, Urs ;
Peters, Nils ;
De Marchis, Gian Marco ;
Guzman, Raphael ;
Nickel, Christian H. ;
Lyrer, Philipp A. ;
Bonati, Leo H. ;
Tsakiris, Dimitrios ;
Engelter, Stefan .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (01) :112-116
[29]   Recanalization Therapies in Acute Ischemic Stroke Patients Impact of Prior Treatment With Novel Oral Anticoagulants on Bleeding Complications and Outcome A Pilot Study [J].
Seiffge, David J. ;
Hooff, Robbert-JanVan ;
Nolte, Christian H. ;
Bejot, Yannick ;
Turc, Guillaume ;
Ikenberg, Benno ;
Berge, Eivind ;
Persike, Malte ;
Dequatre-Ponchelle, Nelly ;
Strbian, Daniel ;
Pfeilschifter, Waltraud ;
Zini, Andrea ;
Tveiten, Arnstein ;
Naess, Halvor ;
Michel, Patrik ;
Sztajzel, Roman ;
Luft, Andreas ;
Gensicke, Henrik ;
Traenka, Christopher ;
Hert, Lisa ;
Scheitz, Jan F. ;
De Marchis, Gian Marco ;
Bonati, Leo H. ;
Peters, Nils ;
Charidimou, Andreas ;
Werring, David J. ;
Palm, Frederick ;
Reinhard, Matthias ;
Niesen, Wolf-Dirk ;
Nagao, Takehiko ;
Pezzini, Alessandro ;
Caso, Valeria ;
Nederkoorn, Paul J. ;
Kagi, Georg ;
von Hessling, Alexander ;
Padjen, Visnja ;
Cordonnier, Charlotte ;
Erdur, Hebun ;
Lyrer, Philippe A. ;
Brouns, Raf ;
Steiner, Thorsten ;
Tatlisumak, Turgut ;
Engelter, Stefan T. .
CIRCULATION, 2015, 132 (13) :1261-1269
[30]   Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants A Systematic Review and Meta-Analysis [J].
Shahjouei, Shima ;
Tsivgoulis, Georgios ;
Goyal, Nitin ;
Sadighi, Alireza ;
Mowla, Ashkan ;
Wang, Ming ;
Seiffge, David J. ;
Zand, Ramin .
STROKE, 2020, 51 (02) :533-541